ReviewFrontiers in immunology2025

Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.

Gala Araujo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.